Your browser doesn't support javascript.
loading
Economic Analysis of Vaccination Programs: An ISPOR Good Practices for Outcomes Research Task Force Report.
Mauskopf, Josephine; Standaert, Baudouin; Connolly, Mark P; Culyer, Anthony J; Garrison, Louis P; Hutubessy, Raymond; Jit, Mark; Pitman, Richard; Revill, Paul; Severens, Johan L.
Afiliación
  • Mauskopf J; RTI Health Solutions, Research Triangle Park, NC, USA. Electronic address: jmauskopf@rti.org.
  • Standaert B; GSK Vaccines, Wavre, Belgium.
  • Connolly MP; University of Groningen, Groningen, The Netherlands; Global Market Access Solutions LLC, Geneva, Switzerland.
  • Culyer AJ; University of York, York, UK.
  • Garrison LP; Department of Pharmacy, The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute, University of Washington, Seattle, WA, USA.
  • Hutubessy R; World Health Organization, Geneva, Switzerland.
  • Jit M; Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine and Public Health, London, UK.
  • Pitman R; ICON, Abingdon, Oxfordshire, UK.
  • Revill P; Centre for Health Economics, University of York, York, UK.
  • Severens JL; Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, The Netherlands; Institute of Medical Technology Assessment, Erasmus University Rotterdam, Rotterdam, The Netherlands.
Value Health ; 21(10): 1133-1149, 2018 10.
Article en En | MEDLINE | ID: mdl-30314613

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Análisis Costo-Beneficio / Programas de Inmunización / Comités Consultivos Tipo de estudio: Guideline / Health_economic_evaluation / Prognostic_studies Límite: Humans Idioma: En Revista: Value Health Asunto de la revista: FARMACOLOGIA Año: 2018 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Análisis Costo-Beneficio / Programas de Inmunización / Comités Consultivos Tipo de estudio: Guideline / Health_economic_evaluation / Prognostic_studies Límite: Humans Idioma: En Revista: Value Health Asunto de la revista: FARMACOLOGIA Año: 2018 Tipo del documento: Article